Tango Therapeutics, Inc.

NASDAQ:TNGX

Biotechnology

Healthcare
$22.71 -10.03%

-$3.24 today

Market cap
$3.85B
Beta
1.19
P/E (TTM)
-38.9
EPS (TTM)
-$0.75
52W Low $4.60High $34.39

Volume 1.81M

Average 3.67M

Balance Sheet

Inspect the capital base behind the business.

Assets

$398.69M

FY 2025 · Annual

+26.0% YoY

Liabilities

$52.51M

FY 2025 · Annual

-55.1% YoY

Equity

$346.18M

FY 2025 · Annual

+73.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents142.75M59.97M66.39M69.53M112.28M
Short-term Investments342.51M306.17M270.5M188.39M230.86M
Net Receivables2M2M000
Inventory00000
Other Current Assets567K7.14M9.65M8.43M10.62M
Total Current Assets492.34M375.27M346.54M266.34M353.76M
Property, Plant & Equipment (Net)6.09M57.77M53.42M47.58M42.49M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.73M3.43M2.61M2.57M2.44M
Total Non-current Assets7.82M61.2M56.03M50.15M44.93M
Total Assets500.16M436.47M402.57M316.49M398.69M
Account Payables3.23M4.45M2.79M1.6M1.18M
Short-term Debt00000
Tax Payables52K35K000
Deferred Revenue26.02M31.79M25.67M17.62M0
Other Current Liabilities666K1.27M7.49M1.74M1.29M
Total Current Liabilities40.69M55.55M45.94M38.17M21.68M
Long-term Debt000030.83M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)114.72M92.09M66.68M44.77M0
Other Non-current Liabilities00000
Total Non-current Liabilities114.72M131.45M103.52M78.81M30.83M
Total Liabilities155.41M186.99M149.46M116.98M52.51M
Common Stock88K88K102K108K136K
Retained Earnings(161.34M)(269.51M)(371.26M)(501.56M)(603.15M)
Accumulated OCI(765K)(3.71M)186K336K224K
Other Stockholders Equity00000
Minority Interest00000
Total Equity344.75M249.48M253.11M199.52M346.18M
Total Debt1.5M41.13M38.92M36.49M33.57M
Net Debt(141.24M)(18.84M)(27.47M)(33.04M)(78.71M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$86.8M
Short-term Investments$890.7M
Other Current$15.2M
Total Current Assets$992.7M
PP&E (Net)$38.4M
Other Non-current$2.4M
Total Non-current Assets$40.8M
Total Assets$1.0B

Analysis

Selected assets total $1.0B for Latest. The largest visible component is Short-term Investments at $890.7M, about 86.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 6, 2026
4Statement of changes in beneficial ownershipNov 4, 2026

How much cash does TNGX have?

Tango Therapeutics, Inc. (TNGX) reported $112.28M in cash and equivalents in fiscal 2025.

How much debt does TNGX carry?

Tango Therapeutics, Inc. (TNGX) reported $33.57M of total debt, with net debt of -$78.71M.